πŸ‡ΊπŸ‡Έ FDA
Patent

US 7521558

Crystalline form of a biphenyl compound

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7521558 (Crystalline form of a biphenyl compound) held by Theravance, Inc. expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P35/00